Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.

Juthaporn CowanSunita MulpuruShawn AaronGonzalo AlvarezAntonio GiuliviVicente Corrales-MedinaVenkatesh ThiruganasambandamoorthyKednapa ThavornRanjeeta MallickD William Cameron

Published in: Pilot and feasibility studies (2018)

ClinicalTrial.gov, NCT03018652 and NCT02690038.

Keyphrases

double blind
study protocol
chronic obstructive pulmonary disease
end stage renal disease
clinical trial
randomized controlled trial
newly diagnosed
prognostic factors
cystic fibrosis
peritoneal dialysis
patient reported outcomes
air pollution